我要投票 腾药在乌鸡白凤丸行业中的票数:248
· 外 推 电 报 ·
2025-02-05 17:46:37 星期三

【腾药是哪个国家的品牌?】

腾药是什么牌子?「腾药」是 云南腾药制药股份有限公司 旗下著名品牌。该品牌发源于云南,由创始人赵丙贤在1990-06-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

腾冲,西南极边第一城,地处中缅边境,是中国古代南丝绸之路的必经之道。这里除了世人皆知的火山热海的奇特自然景观外,得天独厚的生物资源优势,也使之成为发展医药事业的天赐宝地。腾药历史,源远流长,早在北宋年间就有所记载,距今已有800多年。经历代药物学者和名医精研提炼,形成了其优良的品质和独特的风格。

云南省腾冲制药厂创建于上世纪五十年代,至今已有半个世纪的历史,而作为腾冲制药厂的发祥地,为纪念医药先贤“药王”孙思邈而修建的祠堂——“药王宫”则已有370多年的历史。这里荟萃了当地历史上不同流派的著名药店和医家精华,经过几代人的奋斗,早在上世纪七十年代就已步入全国重点中成药厂行列,在云南150多家医药工业企业中具有举足轻重的地位。尤其在产业结构、产品市场份额、专业技术力量、职工队伍素质等方面优势明显,被国家中医药管理局评为全国中药行业“优秀企业”金奖单位,连年被云南省政府评为“省级文明单位”和“先进管理企业”。目前生产的主要剂型有丸剂、冲剂、片剂、酊剂、散剂、糖浆剂、酒剂等七大剂型108个品种,年生产量达千吨以上,产品遍及省内外及东南亚地区,并享有良好的声誉。其中人参再造丸、大活络丸、六味地黄丸、感冒疏风片、藿香正气水等被列为云南省名优产品。

为追求领先的产品质量,改进管理水平,提升和打造“腾药”品牌,2002年下半年,药厂投资3500万元兴建现代化的GMP厂房,引进国际先进的制药机械更新生产线。目前,GMP厂房拥有七条现代化生产线,效率提高了3-4倍,并于2003年11月顺利通过了GMP认证。

为适应现代企业的要求,追求更高更快的发展,跨入新世纪,腾冲制药厂在现代企业制度的指导下,将走规模化和集团化的道路,促进新产品的开发和引进,充分发挥云南天然植物药的特色和优势,为云南医药产业的腾飞作出积极贡献!

英文翻译:Tengchong, the first city on the southwest pole, is located at the border between China and Myanmar, which is the only way along the ancient Southern Silk Road of China. In addition to the world's well-known unique natural landscape, the unique advantages of biological resources also make it a heaven-given treasure for the development of medicine. It has a long history. It was recorded as early as the Northern Song Dynasty. It has been more than 800 years since then. Through the refined research and refinement of modern medicine scholars and famous doctors, it has formed its excellent quality and unique style. Yunnan Tengchong pharmaceutical factory, founded in the 1950s, has a history of half a century. As the birthplace of Tengchong pharmaceutical factory, the ancestral hall "Yaowang Palace" built to commemorate Sun Simiao, the medicine sage, has a history of more than 370 years. It has gathered the essence of famous pharmacies and doctors in different schools in the local history. After several generations of struggle, it has entered the ranks of key Chinese patent medicine factories in the 70s of last century. It has a pivotal position in more than 150 pharmaceutical industrial enterprises in Yunnan. In particular, it has obvious advantages in industrial structure, product market share, professional and technical strength, staff quality, etc. it has been awarded the gold medal unit of "excellent enterprise" in the national traditional Chinese medicine industry by the State Administration of traditional Chinese medicine, and the "provincial civilized unit" and "advanced management enterprise" by the Yunnan provincial government for successive years. At present, there are 108 kinds of seven dosage forms, including pill, granule, tablet, tincture, powder, syrup, liquor, etc., with annual production of more than 1000 tons. The products are all over the province and Southeast Asia, and enjoy a good reputation. Among them, Renshen Zaizai Wan, Dahuoluo Wan, Liuwei Dihuang Wan, Ganmao Shufeng tablet, Huoxiang Zhengqi water are listed as famous and excellent products in Yunnan Province. In order to pursue the leading product quality, improve the management level, enhance and create the "tengyao" brand, in the second half of 2002, the pharmaceutical factory invested 35 million yuan to build a modern GMP plant, and introduced the international advanced pharmaceutical machinery to update the production line. At present, GMP plant has seven modern production lines, the efficiency has increased 3-4 times, and passed GMP certification in November 2003. In order to meet the requirements of modern enterprises, pursue higher and faster development, and stride into the new century, under the guidance of modern enterprise system, Tengchong pharmaceutical factory will take the road of scale and collectivization, promote the development and introduction of new products, give full play to the characteristics and advantages of Yunnan natural plant medicine, and make positive contributions to the take-off of Yunnan pharmaceutical industry!

本文链接: https://www.waitui.com/brand/10f3ee07f.html 联系电话:08755133464

千城特选小程序码

7×24h 快讯

九洲药业:子公司浙江瑞博通过美国FDA现场检查

36氪获悉,九洲药业公告,公司子公司浙江瑞博制药有限公司于2024年10月28日至2024年11月1日期间接受了美国食品药品监督管理局的cGMP现场检查,检查范围涵盖质量体系、物料、生产、包装与标签、设备设施、实验室控制六大系统。近日,浙江瑞博收到美国FDA签发的现场检查报告(EIR,Establishment Inspection Report),该报告表明浙江瑞博已通过本次cGMP现场检查。检查范围为浙江瑞博涉及产品(非无菌原料药卡马西平、文拉法辛苯磺酸盐 —水合物以及药物中间体沙库巴曲)的生产制造。

2小时前

美图:公司旗下产品采用了DeepSeek技术

36氪获悉,据摩根士丹利透露,美图公司旗下的美图设计室已采用DeepSeek技术,主要为AI生成PPT相关功能。

2小时前

硅业分会:多晶硅企业年后集中签单在即,硅料环节持续去库

36氪获悉,据中国有色金属工业协会硅业分会消息,本周逢春节假期,多晶硅企业整体暂无规模性签单,多晶硅市场价格维持稳定。n型复投料成交价格区间为3.90-4.50万元/吨,成交均价为4.17万元/吨,n型颗粒硅成交价格区间为3.80-4.10万元/吨,成交均价为3.90万元/吨,p型多晶硅成交价区间为3.20-3.60万元/吨,成交均价为3.40万元/吨。本周多晶硅企业正常执行前期订单,年后订单仍在洽谈中。目前下游硅片企业排产有上调预期,对多晶硅需求量稳步增长。

2小时前

传宁德时代考虑提交香港上市申请,官方暂无回应

今日有消息称,宁德时代据称考虑在未来几周提交香港上市申请。针对此事,宁德时代方面暂无回应。此前,2024年底也有外媒报道称,宁德时代考虑最快于2025年在香港上市,筹集至少50亿美元。(新浪科技)

2小时前

华泰股份:股票连续12个月收盘价均低于每股净资产,公司制定估值提升计划

36氪获悉,华泰股份公告,公司股票连续12个月每个交易日收盘价均低于最近一个会计年度经审计的每股归属于公司普通股股东的净资产,根据《上市公司监管指引第10号——市值管理》的相关规定,华泰股份制定估值提升计划。公司估值提升计划已经公司第十一届董事会第四次会议审议通过。华泰股份估值提升计划将围绕生产经营、现金分红、股份回购、股东增持、投资者关系管理以及信息披露等方面。

2小时前

本页详细列出关于中联的品牌信息,含品牌所属公司介绍,中联所处行业的品牌地位及优势。
咨询